| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |